Berlin - About 1.8 billion euros more than in 2014 will be available next year to supply patients with statutory health insurance with pharmaceuticals. The (KBV) and (GKV) agreed on this at the end of October in the negotiations on the framework for 2015. The nationwide adjustment factors for pharmaceuticals were increased accordingly by 5.5 percent. At the state level, associations of statutory health insurance physicians and health insurance companies can agree on further adjustments, incorporate target agreements or profitability reserves into the number and age structure of the insured , 3 percent increased. The new, high-priced drugs for the treatment of chronic hepatitis C were also taken into account with an additional 700 million euros. In 2015, around one billion euros are available for this. As the KBV emphasizes, the prescription costs for the new hepatitis C drugs are not the subject of the benchmark tests.
KBV and National Association of Statutory Health Insurance Funds agree on framework specifications for Medicines and remedies that serve as the basis for regional negotiations. At the federal level, the following adjustment factors are taken into account: price development, statutory obligation to provide benefits, guidelines from the Federal Joint Committee, use of innovative drugs and shifts between the service areas.